现在他们竟然去申请专利了？！价格要飙升了。

你知道吗？在显微镜下，一些胶质母细胞瘤组织看起来会像绦虫幼虫。
没错，“终末期脑瘤”和一种寄生虫居然会有惊人的相似之处。
那为什么肿瘤科医生不常规做寄生虫检测？
因为治疗方法太便宜了。

引入主角：甲苯咪唑（Mebendazole）——这种一片几分钱的驱虫药。
曾经被嘲笑、被否定……直到约翰霍普金斯在 2021 年为“肿瘤治疗”申请了一个新版本的专利。
突然间，这个“没用的驱虫药”变得可以申请专利、可以赚钱了。
好笑吗？一点也不好笑。像极了普通罪犯的套路。

与此同时，一个胶质母细胞瘤的诊断能带来超过 60 万英镑 的收入：
化疗、放疗、副作用、感染、药物、扫描，甚至停车费。
你遇到过穷的肿瘤科医生吗？或者缺钱的肿瘤医院？
没有，你才是他们的“现金奶牛”。

寄生虫检测？
大概 £40。
可它却可能威胁整套商业模式。
投资者是谁？就住在那座山上的大房子里——叫做“议会”的地方。

这跟科学无关。
这关乎利润。利润高于健康。

Oh… now they patent it?! The price will soar.

Did you know some glioblastoma tissue can resemble tapeworm larvae under the microscope?
Yes, the “terminal brain tumour” and a parasite can look deceptively similar.
So why don’t oncologists routinely test for parasites?
Because the treatment is cheap.

Enter Mebendazole , the humble pennies-per-tablet dewormer.
Mocked, dismissed… until Johns Hopkins patented a new version in 2021 for “treatment of tumours.”
Suddenly the “useless dewormer” becomes patentable and profitable.
Funny, that. But not really. Common criminals.
Meanwhile, a glioblastoma diagnosis generates £600,000+ in revenue:
chemo, radiotherapy, side-effects, infections, drugs, scans, and even the car park fees. Did you have a poor oncologist? Or oncology hospital that is short on cash? No, you are the cash cow remember.

A parasite test?
About £40.
And it threatens the whole business model.
And who are the investors? They work in that big house on the hill called Parliament!

This isn’t about science.
This is about profit. Profit over Health.